Allogenic
Showing 1 - 25 of 837
Knee Osteoarthritis Trial (Allogenic adipose derived mesenchymal stem cells (AD-MSC), Saline)
Not yet recruiting
- Knee Osteoarthritis
- Allogenic adipose derived mesenchymal stem cells (AD-MSC)
- Saline
- (no location specified)
Jun 26, 2023
EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV Infection After Allogenic HSCT
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 3, 2023
Heart Failure, Systolic Trial (CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs))
Not yet recruiting
- Heart Failure, Systolic
- CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)
- (no location specified)
Jun 22, 2023
Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)
Recruiting
- Acute Myeloid Leukemia
- allogenic NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
Aging Frailty Trial in Abu Dhabi (StromaForte)
Recruiting
- Aging Frailty
- StromaForte
-
Abu Dhabi, United Arab EmiratesBurjeel Medical City
Oct 2, 2023
Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- allogenic CD19-CAR-NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023
Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin's Lymphoma
- Allogenic CD19-CAR-γδT cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Jan 31, 2023
![](/image/sponsor/state-financed_health_facility_"samara_regional_medical_center_dinasty")
Cerebral Palsy Trial in Samara (CP CB-MNC injection, Standard therapy)
Recruiting
- Cerebral Palsy
- CP CB-MNC injection
- Standard therapy
-
Samara, Russian FederationMedical Centre Dinasty
Jan 17, 2023
Gingival Recession Trial in Ann Arbor (Tunneled coronally advanced flap)
Enrolling by invitation
- Gingival Recession
- Tunneled coronally advanced flap
-
Ann Arbor, MichiganUniversity of Michigan - Ann Arbor
Apr 5, 2023
Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)
Recruiting
- Brain Gliomas
- Allogenic B7H3 CAR-γδT cell
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023
Knee Osteoarthritis Trial in Shanghai, Beijing, Hangzhou (Mesenchymal progenitor cells, Sodium Hyaluronate Injection)
Not yet recruiting
- Knee Osteoarthritis
- Mesenchymal progenitor cells
- Sodium Hyaluronate Injection
-
Shanghai, Shanghai, China
- +5 more
Aug 9, 2023
Kidney Cancer Trial in Tampa, Atlanta, Nashville (Blood Sparing Protocol, Standard Blood Replacement)
Suspended
- Kidney Cancer
- Blood Sparing Protocol
- Standard Blood Replacement
-
Tampa, Florida
- +2 more
Aug 26, 2022
Spinal Cord Injury, Acute Trial in Moscow (Multiple systemic (i.v.) administration of allogenic non-related group- and
Recruiting
- Spinal Cord Injury, Acute
- Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells
- Control vehicle (sterile saline)
-
Moscow, Russian FederationN.V. Sklifosovsky Emergency Care Institute
Jan 12, 2023
Postoperative Hypoparathyroidism Trial (Allogenic parathyroid cells, Standard treatment according to the Clinical protocols)
Not yet recruiting
- Postoperative Hypoparathyroidism
- Allogenic parathyroid cells
- Standard treatment according to the Clinical protocols
- (no location specified)
Jan 12, 2022
Ligneous Conjunctivitis, Left Eye Trial in St. John's (Allogenic plasma aliquots, a source of plasminogen)
Enrolling by invitation
- Ligneous Conjunctivitis, Left Eye
- Allogenic plasma aliquots, a source of plasminogen
-
St. John's, Newfoundland and Labrador, CanadaMemorial University of Newfoundland
Apr 5, 2022
Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)
Recruiting
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia Recurrent
- CD123-CAR-NK cells
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022
Palatal Wound Trial in Houston (Allogenic amnion chorion membrane, Collagen dressing)
Completed
- Palatal Wound
- Allogenic amnion chorion membrane
- Collagen dressing
-
Houston, TexasThe University of Texas Health Science Center at Houston
Dec 17, 2021
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)
Recruiting
- CMV Infection After Allogenic HSCT
- CMV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 5, 2021
Recurrent Glioblastoma Trial in Jacksonville (Allogeneic Adipose-derived Mesenchymal Stem Cells, Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma
- Allogeneic Adipose-derived Mesenchymal Stem Cells
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 16, 2023
MDS Trial in Bari, Rozzano (bone marrow withdrawal)
Recruiting
- Myelodysplastic Syndromes
- bone marrow withdrawal
-
Bari, Italy
- +6 more
Oct 10, 2022
Burn Wound, Second- or Third-degree Burn Trial in Caracas (Implantation of allogeneic MSCs on burn wounds)
Enrolling by invitation
- Burn Wound
- Second- or Third-degree Burn
- Implantation of allogeneic MSCs on burn wounds
-
Caracas, Miranda, VenezuelaInstituto Venezolano de Investigaciones Cientificas
Oct 23, 2023
Parkinson Disease Trial in San José (PASC transplantation (25 million PASCs/patient), Control)
Active, not recruiting
- Parkinson Disease
- PASC transplantation (25 million PASCs/patient)
- Control
-
San José, Costa Rica
- +1 more
Nov 28, 2023
